Dr. Nicolae Leca
Nephrology (Kidney) (Nephrology Physician)
University Of Washington Medical Ctr, 1959 Ne Pacific St
Seattle, WA 98195
Who else practices at this address →
King County includes primary care (5% of residents) and dental (4% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 161
Licensed in Washington since 2005, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
WA license MD00045108 (first issued 2005; active) -
Internal Medicine Physician
WA license MD00045108 (first issued 2005; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Washington Medical Ctr Seattle, WA
- Tacoma General Allenmore Hospital Tacoma, WA
- Providence Alaska Medical Center Anchorage, AK
- Skagit Valley Hospital Mount Vernon, WA
- Kittitas Valley Community Hospital Ellensburg, WA
Medical groups
- The Association of University Physicians (3,535 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 161
- Services billed
- 710
- Patients’ average age
- 61
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 348 | 134 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 131 | 50 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 49 | 23 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 22 | 20 |
| Established patient office or other outpatient visit, 30-39 minutes | 20 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 53 payments worth $65,828 in total to this clinician.
| Travere Therapeutics, Inc. | $22,374 |
|---|---|
| Alexion Pharmaceuticals, Inc. | $13,948 |
| Sanofi-aventis U.S. LLC | $13,463 |
| Novartis Pharmaceuticals Corporation | $9,041 |
| Veloxis Pharmaceuticals, Inc. | $4,480 |
| Calliditas Therapeutics US Inc. | $2,481 |
| Amgen Inc. | $41.59 |
| Consulting Fee | $57,642 |
|---|---|
| Travel and Lodging | $6,049 |
| Food and Beverage | $2,137 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. Nov 11, 2025 | Consulting Fee | $12,950 |
| Alexion Pharmaceuticals, Inc. Dec 4, 2025 | Consulting Fee ULTOMIRIS · Rare Disease | $11,725 |
| Sanofi-aventis U.S. LLC Nov 25, 2025 | Consulting Fee | $8,671 |
| Novartis Pharmaceuticals Corporation Oct 21, 2025 | Consulting Fee Fabhalta · Immunology | $7,700 |
| Travere Therapeutics, Inc. Nov 18, 2025 | Consulting Fee | $6,300 |
| Veloxis Pharmaceuticals, Inc. Nov 27, 2025 | Consulting Fee ENVARSUS · TRANSPLANTATION | $4,480 |
| Sanofi-aventis U.S. LLC Oct 28, 2025 | Consulting Fee | $3,335 |
| Calliditas Therapeutics US Inc. Aug 21, 2025 | Consulting Fee TARPEYO · NEPHROLOGY | $2,481 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $1,010 |
| Alexion Pharmaceuticals, Inc. Nov 3, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind Company’s descriptionConsulting Expenses | $917 |
All 28 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. Dec 4, 2025 | Consulting Fee ULTOMIRIS · Rare Disease | $11,725 |
| Veloxis Pharmaceuticals, Inc. Nov 27, 2025 | Consulting Fee ENVARSUS · TRANSPLANTATION | $4,480 |
| Sanofi-aventis U.S. LLC Nov 25, 2025 | Consulting Fee | $8,671 |
| Sanofi-aventis U.S. LLC Nov 25, 2025 | Travel and Lodging travel to Southlake, TX · in-kind | $689 |
| Sanofi-aventis U.S. LLC Nov 25, 2025 | Travel and Lodging travel to Southlake, TX | $74.00 |
| Sanofi-aventis U.S. LLC Nov 21, 2025 | Travel and Lodging travel to Southlake, TX · in-kind | $271 |
| Travere Therapeutics, Inc. Nov 18, 2025 | Consulting Fee | $6,300 |
| Travere Therapeutics, Inc. Nov 18, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $125 |
| Travere Therapeutics, Inc. Nov 18, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $30.80 |
| Travere Therapeutics, Inc. Nov 11, 2025 | Consulting Fee | $12,950 |
| Travere Therapeutics, Inc. Nov 11, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $74.00 |
| Alexion Pharmaceuticals, Inc. Nov 4, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind Company’s descriptionConsulting Expenses | $350 |
| Alexion Pharmaceuticals, Inc. Nov 3, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind Company’s descriptionConsulting Expenses | $917 |
| Alexion Pharmaceuticals, Inc. Nov 3, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind Company’s descriptionConsulting Expenses | $350 |
| Alexion Pharmaceuticals, Inc. Nov 3, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Seattle, WA Company’s descriptionConsulting Expenses | $87.97 |
| Alexion Pharmaceuticals, Inc. Nov 2, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Houston, TX Company’s descriptionConsulting Expenses | $53.05 |
| Sanofi-aventis U.S. LLC Oct 28, 2025 | Consulting Fee | $3,335 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $1,010 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Denver, CO · in-kind | $446 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Denver, CO · in-kind | $287 |
| Novartis Pharmaceuticals Corporation Oct 21, 2025 | Consulting Fee Fabhalta · Immunology | $7,700 |
| Novartis Pharmaceuticals Corporation Oct 21, 2025 | Travel and Lodging Fabhalta · Immunology · travel to East Hanover, NJ | $74.00 |
| Travere Therapeutics, Inc. Oct 11, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $240 |
| Novartis Pharmaceuticals Corporation Oct 2, 2025 | Travel and Lodging Fabhalta · Immunology · travel to East Hanover, NJ · in-kind | $343 |
| Novartis Pharmaceuticals Corporation Oct 2, 2025 | Travel and Lodging Fabhalta · Immunology · travel to East Hanover, NJ | $262 |
| Novartis Pharmaceuticals Corporation Oct 2, 2025 | Travel and Lodging Fabhalta · Immunology · travel to East Hanover, NJ | $27.63 |
| Novartis Pharmaceuticals Corporation Oct 1, 2025 | Travel and Lodging travel to Morristown, NJ · in-kind | $337 |
| Calliditas Therapeutics US Inc. Aug 21, 2025 | Consulting Fee TARPEYO · NEPHROLOGY | $2,481 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $17,131 in research payments for these studies, mostly to the institutions running them.
- Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
Csl Behring · Terminated · NCT03744910
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.